For Sales
From
Description
30 Respiratory is our innovative respiratory disease platform consisting of a range of inhaled assets based on our proprietary nitric oxide-generating technology.
These inhaled products are far more potent against even highly drug resistant bacteria than the current standard of care antibiotics and combine this outstanding activity with an extremely broad spectrum of action and superb safety profile.